Teva Pharmaceutical Industries Limited (TEV) — Strategic Asset Allocation Index
Teva Pharmaceutical Industries Limited (TEV) has a Strategic Asset Allocation Index of 79.5% as of June 2023. Strategic assets (PP&E of €6.13 Billion plus long-term investments of €-) total €6.13 Billion, measured against net assets of €7.71 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Teva Pharmaceutical Industries Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Teva Pharmaceutical Industries Limited Strategic Asset Allocation Index (2015–2022)
This chart shows how Teva Pharmaceutical Industries Limited's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of June 2023, the index stands at 79.5%, representing strategic assets of €6.13 Billion against net assets of €7.71 Billion EUR. See Teva Pharmaceutical Industries Limited free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Teva Pharmaceutical Industries Limited (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Teva Pharmaceutical Industries Limited from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Teva Pharmaceutical Industries Limited market cap and net worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 70.9% | €6.16 Billion | €6.16 Billion | €- | €8.69 Billion | ▲ +13.3 pp |
| 2021 | 57.6% | €6.48 Billion | €6.48 Billion | €- | €11.24 Billion | ▼ -4.4 pp |
| 2020 | 62.0% | €6.86 Billion | €6.86 Billion | €- | €11.06 Billion | ▲ +15.8 pp |
| 2019 | 46.1% | €6.95 Billion | €6.95 Billion | €- | €15.06 Billion | ▲ +2.3 pp |
| 2018 | 43.9% | €6.93 Billion | €6.87 Billion | €61.00 Million | €15.79 Billion | ▲ +5.9 pp |
| 2017 | 38.0% | €7.12 Billion | €7.04 Billion | €83.00 Million | €18.75 Billion | ▲ +15.9 pp |
| 2016 | 22.1% | €7.72 Billion | €7.44 Billion | €283.00 Million | €34.99 Billion | ▼ -2.9 pp |
| 2015 | 25.0% | €7.47 Billion | €6.02 Billion | €1.45 Billion | €29.93 Billion | — |